@article{ART000855934,
author={So Eun Kim and 김찬규 and Kyu Taeg Lee and 박성규 and 백승호 and 홍대식 and 박희숙 and Hugh ChulKim and 원종호 and Hyun Soo Kim and Joon Sung Park},
title={High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Persistent/Relapsed OvarianCancer},
journal={Cancer Research and Treatment},
issn={1598-2998},
year={2002},
volume={34},
number={6},
pages={439-443}
}

TY - JOUR
AU - So Eun Kim
AU - 김찬규
AU - Kyu Taeg Lee
AU - 박성규
AU - 백승호
AU - 홍대식
AU - 박희숙
AU - Hugh ChulKim
AU - 원종호
AU - Hyun Soo Kim
AU - Joon Sung Park
TI - High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Persistent/Relapsed OvarianCancer
T2 - Cancer Research and Treatment
JO - Cancer Research and Treatment
PY - 2002
VL - 34
IS - 6
PB - 대한암학회
SP - 439
EP - 443
SN - 1598-2998
AB - Purpose: High dose chemotherapy (HDC) is increasinglybeing used for ovarian cancer. Although earlystudies of autotransplantation for advanced ovarian cancerhave been encouraging, most reported series weresmall, and no randomized trials have been reported. HDCand autologous hematopoietic stem cell transplantationwere rarely performed in patients with ovarian cancer inKorea, and no results have been reported with theexception of one case report. Materials and Methods: We retrospectively analyzed 10patients with refractory or relapsed ovarian cancer havingreceived HDC and autologous peripheral blood stem celltransplantation (APBSCT), between January 1996 andSeptember 1998, at the Soon Chun Hyang and AjouUniversity Hospitals. Results: Ten patients were treated with HDC andAPBSCT. Six patients achieved complete response (CR)and 1 a partial response (PR), with a response rate of70%. Three patients did not respond following mobilizationchemotherapy, and failed to respond after HDC. The median duration of progression free survival (PFS)and overall survival (OS) were 6 (4∼46) and 13 (3∼50+)months, respectively. The median duration of OS of theresponders following mobilization chemotherapy was 23(8∼50+) compared with 12 (3∼18) months of the nonresponders. With regard to the treatment related toxicity,8 patients had neutropenic fevers, and bacteremia wasdocumented in 4. The non-hematological toxicities werenever life threatening, and there were no treatment relateddeaths. Conclusion: HDC, followed by APBSCT, is well-toleratedpatients with refractory or relapsed ovarian cancer, andfollowing mobilization chemotherapy the responderssurvived longer than the non-responders. (Cancer Res Treat. 2002;34:439-443)
KW - Ovarian neoplasm, High dose chemotherapy, Stem cell transplantation
DO -
UR -
ER -

So Eun Kim, 김찬규, Kyu Taeg Lee, 박성규, 백승호, 홍대식, 박희숙, Hugh ChulKim, 원종호, Hyun Soo Kim and Joon Sung Park. 2002, "High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Persistent/Relapsed OvarianCancer", Cancer Research and Treatment, vol.34, no.6 pp.439-443.

So Eun Kim, 김찬규, Kyu Taeg Lee, 박성규, 백승호, 홍대식, 박희숙, Hugh ChulKim, 원종호, Hyun Soo Kim, Joon Sung Park "High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Persistent/Relapsed OvarianCancer" Cancer Research and Treatment 34.6 pp.439-443 (2002) : 439.

So Eun Kim, 김찬규, Kyu Taeg Lee, 박성규, 백승호, 홍대식, 박희숙, Hugh ChulKim, 원종호, Hyun Soo Kim, Joon Sung Park. High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Persistent/Relapsed OvarianCancer. 2002; 34(6), 439-443.

So Eun Kim, 김찬규, Kyu Taeg Lee, 박성규, 백승호, 홍대식, 박희숙, Hugh ChulKim, 원종호, Hyun Soo Kim and Joon Sung Park. "High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Persistent/Relapsed OvarianCancer" Cancer Research and Treatment 34, no.6 (2002) : 439-443.

So Eun Kim; 김찬규; Kyu Taeg Lee; 박성규; 백승호; 홍대식; 박희숙; Hugh ChulKim; 원종호; Hyun Soo Kim; Joon Sung Park. High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Persistent/Relapsed OvarianCancer. Cancer Research and Treatment, 34(6), 439-443.

So Eun Kim; 김찬규; Kyu Taeg Lee; 박성규; 백승호; 홍대식; 박희숙; Hugh ChulKim; 원종호; Hyun Soo Kim; Joon Sung Park. High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Persistent/Relapsed OvarianCancer. Cancer Research and Treatment. 2002; 34(6) 439-443.

So Eun Kim, 김찬규, Kyu Taeg Lee, 박성규, 백승호, 홍대식, 박희숙, Hugh ChulKim, 원종호, Hyun Soo Kim, Joon Sung Park. High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Persistent/Relapsed OvarianCancer. 2002; 34(6), 439-443.

So Eun Kim, 김찬규, Kyu Taeg Lee, 박성규, 백승호, 홍대식, 박희숙, Hugh ChulKim, 원종호, Hyun Soo Kim and Joon Sung Park. "High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Persistent/Relapsed OvarianCancer" Cancer Research and Treatment 34, no.6 (2002) : 439-443.